168 related articles for article (PubMed ID: 18507028)
1. Prognostic value of protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Yamaguchi A
Anticancer Res; 2008; 28(2A):847-54. PubMed ID: 18507028
[TBL] [Abstract][Full Text] [Related]
2. Expression of protease activated receptor-2 (PAR-2) in gastric cancer.
Fujimoto D; Hirono Y; Goi T; Katayama K; Hirose K; Yamaguchi A
J Surg Oncol; 2006 Feb; 93(2):139-44. PubMed ID: 16425301
[TBL] [Abstract][Full Text] [Related]
3. Correlation of lymph node metastases and expression of matrix metalloproteinase-7 in patients with gastric cancer.
Ajisaka H; Yonemura Y; Miwa K
Hepatogastroenterology; 2004; 51(57):900-5. PubMed ID: 15143943
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of matrix metalloproteinase-1 and proteinase-activated receptor-1 promotes the progression of human gliomas.
Zhang Y; Zhan H; Xu W; Yuan Z; Lu P; Zhan L; Li Q
Pathol Res Pract; 2011 Jan; 207(1):24-9. PubMed ID: 21087829
[TBL] [Abstract][Full Text] [Related]
5. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological and prognostic significance of MUC-1 expression in Japanese gastric carcinomas: an immunohistochemical study of tissue microarrays.
Li XH; Zheng HC; Wang ZG; Takahashi H; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(2A):1061-7. PubMed ID: 18507055
[TBL] [Abstract][Full Text] [Related]
7. Correlation between MMP1-PAR1 axis and clinical outcome of primary gallbladder carcinoma.
Du X; Wang S; Lu J; Cao Y; Song N; Yang T; Dong R; Zang L; Yang Y; Wu T; Li J
Jpn J Clin Oncol; 2011 Sep; 41(9):1086-93. PubMed ID: 21835828
[TBL] [Abstract][Full Text] [Related]
8. PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells.
Boire A; Covic L; Agarwal A; Jacques S; Sherifi S; Kuliopulos A
Cell; 2005 Feb; 120(3):303-13. PubMed ID: 15707890
[TBL] [Abstract][Full Text] [Related]
9. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer.
Tang Y; Zhu J; Chen L; Chen L; Zhang S; Lin J
Clin Cancer Res; 2008 May; 14(9):2870-7. PubMed ID: 18451255
[TBL] [Abstract][Full Text] [Related]
10. Amplification of MMP-2 and MMP-9 production by prostate cancer cell lines via activation of protease-activated receptors.
Wilson SR; Gallagher S; Warpeha K; Hawthorne SJ
Prostate; 2004 Jul; 60(2):168-74. PubMed ID: 15162383
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase-9 activity is associated with poor prognosis in T3-T4 node-negative colorectal cancer.
Cho YB; Lee WY; Song SY; Shin HJ; Yun SH; Chun HK
Hum Pathol; 2007 Nov; 38(11):1603-10. PubMed ID: 17669467
[TBL] [Abstract][Full Text] [Related]
12. Expression of reversion-inducing-cysteine-rich protein with Kazal motifs (RECK) as a prognostic indicator in gastric cancer.
Song SY; Son HJ; Nam E; Rhee JC; Park C
Eur J Cancer; 2006 Jan; 42(1):101-8. PubMed ID: 16324834
[TBL] [Abstract][Full Text] [Related]
13. Arp2/3 overexpression contributed to pathogenesis, growth and invasion of gastric carcinoma.
Zheng HC; Zheng YS; Li XH; Takahashi H; Hara T; Masuda S; Yang XH; Guan YF; Takano Y
Anticancer Res; 2008; 28(4B):2225-32. PubMed ID: 18751399
[TBL] [Abstract][Full Text] [Related]
14. Galectin-3 facilitates cell motility in gastric cancer by up-regulating protease-activated receptor-1 (PAR-1) and matrix metalloproteinase-1 (MMP-1).
Kim SJ; Shin JY; Lee KD; Bae YK; Choi IJ; Park SH; Chun KH
PLoS One; 2011; 6(9):e25103. PubMed ID: 21966428
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical evaluation of the tumor neoangiogenesis as a prognostic factor for gastric cancers.
Lazăr D; Tăban S; Raica M; Sporea I; Cornianu M; Goldiş A; Vernic C
Rom J Morphol Embryol; 2008; 49(2):137-48. PubMed ID: 18516318
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of matrix metalloproteinase-2 (MMP-2) expression in endometrial endometrioid adenocarcinoma.
Talvensaari-Mattila A; Santala M; Soini Y; Turpeenniemi-Hujanen T
Anticancer Res; 2005; 25(6B):4101-5. PubMed ID: 16309203
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of p12 is associated with more advanced tumor invasion in human gastric cancer tissues.
Choi MG; Sohn TS; Park SB; Paik YH; Noh JH; Kim KM; Park CK; Kim S
Eur Surg Res; 2009; 42(4):223-9. PubMed ID: 19279387
[TBL] [Abstract][Full Text] [Related]
18. Serum matrix metalloproteinase-9 level associated with stromal reaction in patients with gastric cancer.
Shen KH; Chi CW; Lo SS; Kao HL; Lui WY; Wu CW
Anticancer Res; 2000; 20(2B):1307-10. PubMed ID: 10810440
[TBL] [Abstract][Full Text] [Related]
19. Expression of protease-activated receptor-2 (PAR-2) in patients with nasopharyngeal carcinoma: correlation with clinicopathological features and prognosis.
Li Z; Bian LJ; Li Y; Liang YJ; Liang HZ
Pathol Res Pract; 2009; 205(8):542-50. PubMed ID: 19269113
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer.
Buergy D; Fuchs T; Kambakamba P; Mudduluru G; Maurer G; Post S; Tang Y; Nakada MT; Yan L; Allgayer H
Cancer; 2009 Oct; 115(20):4667-78. PubMed ID: 19569245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
